Literature DB >> 8072013

Cardiac hypertrophy alters expression of Na+,K(+)-ATPase subunit isoforms at mRNA and protein levels in rat myocardium.

C B Book1, R L Moore, A Semanchik, Y C Ng.   

Abstract

In myocardium from different rat models of cardiac hypertrophy, expression of Na+,K(+)-ATPase isoforms has been shown to be altered at the mRNA level. However, it has not been determined whether these alterations translate into changes at the protein level. This distinction is important because post-transcriptional events have been shown to regulate isoform expression. In the present study, relative abundances of the Na+,K(+)-ATPase isoforms were examined in hypertrophied left ventricles of renovascular hypertensive rats at both the protein and mRNA levels, using immunoblotting and dot blot hybridization, respectively. Stenosis of the left renal artery elicited an increase in systolic blood pressure, cardiac hypertrophy, and a shift in expression of the myosin heavy chain isoforms. In hypertrophied left ventricles, expression of the alpha 1 isoform remained unchanged at both mRNA and protein levels, whereas the relative abundances of both alpha 2-mRNA and -protein decreased, to 0.63 and 0.54, respectively, of controls. In addition, the abundance of beta 1-mRNA remained unchanged, whereas beta 1-protein decreased to 0.67 of controls. These results suggest that in hypertrophied myocardium of renovascular hypertensive rats Na+,K(+)-ATPase isoform expression is altered at both the protein and mRNA levels, and that pretranslational as well as translational/post-translational mechanisms may be involved.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8072013     DOI: 10.1006/jmcc.1994.1071

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  11 in total

1.  Na+ -transport modulation induces isoform-specific expression of Na+,K+ -Atpase alpha-subunit isoforms in C2C12 skeletal muscle cell.

Authors:  R Ladka; Y C Ng
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

Review 2.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 3.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

Review 4.  Regulation of the Na+/K+-ATPase by insulin: why and how?

Authors:  G Sweeney; A Klip
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

5.  Intra-uterine growth restriction and the programming of left ventricular remodelling in female rats.

Authors:  Marie-Claude Battista; Ezequiel Calvo; Alzbeta Chorvatova; Blandine Comte; Jacques Corbeil; Michèle Brochu
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

6.  Expression and activity of the glutamate transporter EAAT2 in cardiac hypertrophy: implications for ischaemia reperfusion injury.

Authors:  Nicola King; Hua Lin; John D McGivan; M Saadeh Suleiman
Journal:  Pflugers Arch       Date:  2006-05-23       Impact factor: 3.657

7.  Calcium channels and cation transport ATPases in cardiac hypertrophy induced by aortic constriction in newborn rats.

Authors:  L Zheng; M Wibo; F Kolár; T Godfraind
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

8.  Reduced concentration of myocardial Na+,K(+)-ATPase in human aortic valve disease as well as of Na+,K(+)- and Ca(2+)-ATPase in rodents with hypertrophy.

Authors:  J S Larsen; T A Schmidt; H Bundgaard; K Kjeldsen
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

9.  Altered expression of Na+ transporters at the mRNA level in rat normal and hypertrophic myocardium.

Authors:  Taku Yamamoto; Takeshi Shirayama; Tomosaburo Takahashi; Hiroaki Matsubara
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

10.  Ouabain prevents pathological cardiac hypertrophy and heart failure through activation of phosphoinositide 3-kinase α in mouse.

Authors:  Jian Wu; Daxiang Li; Lingling Du; Mustafa Baldawi; Marjorie E Gable; Amir Askari; Lijun Liu
Journal:  Cell Biosci       Date:  2015-11-18       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.